Scientists map protein interactions tied to neurodegenerative disease

Researchers have identified how a protein linked to Alzheimer's disease binds to metabolic enzymes in the cell, potentially opening new drug targets. The discovery could help pharmaceutical companies develop therapies that intercept disease mechanisms earlier, before significant neurological damage occurs.

Originaltitel: Identification of glycolytic proteins as binding partners of Bri2 BRICHOS domain